综述与进展

以氨基氰为原料合成含氮化合物的研究进展

  • 吴江龙 ,
  • 王中杰 ,
  • 王晨宇 ,
  • 王彦 ,
  • 李红俊 ,
  • 罗辉 ,
  • 李昊 ,
  • 王富强 ,
  • 李典军 ,
  • 杨金会
展开
  • 宁夏大学化学化工学院/省部共建煤炭高效利用与绿色化工国家重点实验室 银川 750021
†共同第一作者

收稿日期: 2022-08-16

  修回日期: 2022-09-18

  网络出版日期: 2022-11-01

基金资助

部委级自然科学其他项目(2019NXZD1); 宁夏自治区科技攻关(支撑)计划(2021BEG02001); 宁夏自治区科技攻关(支撑)计划(2021BEE03003); 及宁夏自治区重点研发计划(2022BDE03009)

Research Progress on the Synthesis of Nitrogen-Containing Compounds with Cyanamide as a Building Block

  • Jianglong Wu ,
  • Zhongjie Wang ,
  • Chenyu Wang ,
  • Yan Wang ,
  • Hongjun Li ,
  • Hui Luo ,
  • Hao Li ,
  • Fuqiang Wang ,
  • Dianjun Li ,
  • Jinhui Yang
Expand
  • College of Chemistry and Chemical Engineering/State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering, Ningxia University, Yinchuan 750021
†(These authors contributed equally to this work).
* Corresponding authors. E-mail: ;

Received date: 2022-08-16

  Revised date: 2022-09-18

  Online published: 2022-11-01

Supported by

Ministry-Level Natural Science Other Projects(2019NXZD1); Scientific and Technological Research (Support) Project of Ningxia(2021BEG02001); Scientific and Technological Research (Support) Project of Ningxia(2021BEE03003); Key Research and Development Project of Ningxia(2022BDE03009)

摘要

含氮化合物存在于许多天然产物中, 具有广泛的药理和生理活性. 它们不仅被广泛应用于医药或农药领域, 在工业及多功能材料等领域也多有应用. 近年来, 含氮化合物的合成方法研究发展迅速, 不断有新的以氨基氰为原料合成各种含氮化合物的反应涌现. 简要介绍了近二十年来, 以氨基氰(NH2-CN)作为原料合成各种含氮化合物的研究进展, 并归纳总结了它们的特点、规律和优劣势, 为它们的合成方法和反应性的研究提供帮助.

本文引用格式

吴江龙 , 王中杰 , 王晨宇 , 王彦 , 李红俊 , 罗辉 , 李昊 , 王富强 , 李典军 , 杨金会 . 以氨基氰为原料合成含氮化合物的研究进展[J]. 有机化学, 2023 , 43(2) : 436 -454 . DOI: 10.6023/cjoc202208020

Abstract

Nitrogen-containing compounds are widely found in many natural products and have a wide range of pharmaco- logical and physiological activities. Furthermore, they have comprehensive applications in medicine and pesticide fields, industry and multi-functional materials. Great advances in the synthesis of these compounds have been sprung up, a diversity of synthetic methods of them via cyanamide (NH2-CN) as raw material were exploited in recent years. The research progress on the synthesis of nitrogen-containing compounds through cyanamide as a building block is introduced comprehensively. Moreover, their characteristics, rules, advantages and disadvantages are summarized and discussed for the development of new synthetic methodologies and reactions of nitrogen-containing compounds.

参考文献

[1]
Romagnoli, R.; Baraldi, P. G.; Carrion, M. D. J. Med. Chem. 2009, 52, 5551.
[2]
Abdelazeem, A. H.; Abdelatef, S. A.; El-Saadi, M. T. Eur. J. Pharm. Sci. 2014, 62,197.
[3]
Zhu, Y.; Loso, M. R.; Watson, G. B. J. Agric. Food Chem. 2011, 59, 2950.
[4]
Lainé, D.; Palovich, M.; McCleland, B. ACS Med. Chem. Lett. 2011, 2, 142.
[5]
Stafford, J. A.; Feldman, P. L. Annu. Rep. Med. Chem. 1996, 31,71.
[6]
David, H. D.; Samuel, W. G.; James, A. L. Tetrahedron Lett. 1997, 38, 3377.
[7]
Berlinck, R. G. S. Fortschr. Chem. Org. Naturst. 1995, 66,119.
[8]
Castagnolo, D.; Schenone, S.; Botta, M. Chem. Rev. 2011, 111, 5247.
[9]
Patrick, C. K.; Monica, F.; John, A. F. Tetrahedron Lett. 1998, 39, 2663.
[10]
Kamo, T.; Endo, M.; Sato, M. Phytochemistry 2008, 69, 1166.
[11]
Chen, X.; Orser, B. A.; MacDonald, J. F. Eur. J. Pharmacol. 2010, 648, 15.
[12]
Ojo, B.; Dunbar, P. G.; Durant, G. J. Bioorg. Med. Chem. 1996, 4, 1605.
[13]
Cannon, C. P. Clin. Cardiol. 2003, 26, 358.
[14]
Kotthaus, J.; Steinmetzer, T.; van de Locht, A. J. Enzyme Inhib. Med. Chem. 2011, 26, 115.
[15]
Sa?vmarker, J.; Rydfjord, J.; Gising, J.; Odell, L. R.; Larhed, M. Org. Lett. 2012, 14, 2394.
[16]
Rydfjord, J.; Svensson, F.; Trejos, A.; Sj?berg, J. R.; Sk?ld, C.; vmarker, J. S.; Odell, L. R.; Larhed, M. Chem. Small. 2013, 19, 13803.
[17]
Rydfjord, J.; Skillinghaug, B.; Brandt, P.; Odell, L. R.; Larhed, M. Org. Lett. 2017, 19, 4066.
[18]
Klein, M.; Güthner, T.; Sans, J. Green Chem. 2021, 23, 3289-3294.
[19]
(a) Odo, K.; Sugino, K. J. Electrochem. Soc. 1957, 104, 160.
[19]
(b) Ichikawa, E.; Odo, K. Denki Kagaku 1964, 32, 897.
[20]
Katritzky, A. R.; Khashab, N. M.; Bobrov, S. Helv. Chim. Acta 2005, 88, 1664.
[21]
Yong, Y. F.; Kowalski, J.; Lipton, M. J. Org. Chem. 1997, 62, 1540.
[22]
Andrews, D.; Finlay, M. R.; Green, C.; Jones, C.; Oza, V. WO 095159, 2006.
[23]
Bicking, J. B.; Mason, J. W.; Woltersdorf Jr, O. W. J. Med. Chem. 1965, 8, 638.
[24]
Pacha, W.; Salzmann, R.; Scholtysik, G. Br. J. British. J. Pharmacol. 1975, 53, 513.
[25]
?kerbladh, L.; Schembri, L S.; Larhed, M.; Odell, L. R. J. Org. Chem. 2017, 82, 12520.
[26]
Miller, A. J. Org. Chem. 1984, 49, 4072.
[27]
Mancheno, O. G.; Bistri, O.; O.; Bolm, C. Org. Lett. 2007, 9, 3809.
[28]
(a) Serban, G. Molecules 2020, 25, 942.
[28]
(b) Gao, F.; Wang, T.; Xiao, J.; Huang, G. Eur. J. Med. Chem. 2019, 173, 274.
[29]
Yin, P.; Ma, W. B.; Chen, Y.; Huang, W. C.; Deng, Y.; He, L. Org. Lett. 2009, 5482.
[30]
(a) Hiskey, M.; Chavez, D. E.; Naud, D. L. Proc. Int. Pyrotech. Semin. 2000, 27, 3.
[30]
(b) Singh, H.; Chawla, A. S.; Kapoor, V. K. Prog. Med. Chem. 1980, 17, 151.
[31]
Moderhack, D. J. Prakt. Chem. 1998, 340, 687.
[32]
García Manche?o, O.; Bolm, C. Org. Lett. 2007, 9, 2951.
[33]
For an example of guanidine synthesis with cyanamide and carbodiimide see: Mestres, R.; Palomo, C. Synthesis 1980, 755.
[34]
Baeten, M.; Maes, B. U. W. Adv. Synth. Catal. 2016, 358, 826.
[35]
Nordeman, P.; Chow, S. Y.; Odell, A. F. Org. Biomol. Chem. 2017, 15, 4875.
[36]
Ma, X. D.; Huang, W.; Yang, Y. Y. CN 112979555, 2021.
[37]
Lunn, W. H. W.; Harper, R. W.; Stone, R. L. J. Med. Chem. 1971, 14, 1069.
[38]
(a) Li, X.; Gan, B.; Xie, T. J. Chem. Res. 2016, 40, 178.
[38]
(b) Hua, G.; Li, Y.; Fuller, A. Eur. J. Org. Chem. 2009, 2009, 1612.
[39]
(a) Bird, C. W. Tetrahedron 1965, 21, 2179.
[39]
(b) Bird, C. W.; Kapilli, M. Tetrahedron 1987, 43, 4621.
[39]
(c) Fadda, A. A.; Refat, H. M.; Zaki, M. E.; Monir, A. E. Synth. Commun. 2001, 31, 3537.
[39]
(d) Carpenter, R. D.; Lam, K. S.; Kurth, M. J. J. Org. Chem. 2007, 72, 284.
[40]
Yang, D. S.; Wang, Y. Y.; Yang, H. J.; Liu, T.; Fu, H. Adv. Synth. Catal. 2012, 354, 477.
[41]
Lou, Z. B.; Wu, X. D.; Yang, H. J.; Zhu, C. J.; Fu, H. Adv. Synth. Catal. 2015, 357, 3961.
[42]
Mishra, N.; Singh, A. S.; Agrahari, A. K.; Singh, S. K.; Singh, M.; Tiwari, V. K. ACS Comb. Sci. 2019, 21, 389.
[43]
Farhanullah; Agarwal, N.; Goel A.; Ram, V. J. J. Org. Chem. 2003, 68, 2983.
[44]
Zhang, L.; Peng, X. M.; Damu, G. L. V. Med. Res. Rev. 2014, 34, 340.
[45]
Anastasi, C.; Crowe, M. A.; Powner, M. W.; Sutherland, J. D. Angew. Chem., nt. Ed. 2006, 45, 6176.
[46]
Fahrenbach, A. C.; Giurgiu, C.; Tam, C. P.; Li, L.; Hongo, Y.; Aono, M.; Szostak, J. W. J. Am. Chem. Soc. 2017, 139, 8780.
[47]
Cohen, S. H.; Gerding, D. N.; Johnson, S. Infect. Control Hosp. Epidemiol. 2010, 31, 431.
[48]
Malamas, M. S.; Erdei, J.; Gunawan, I. J. Med. Chem. 2010, 53, 1146.
[49]
Li, W. T.; Hwang, D. R.; Song, J. S. J. Med. Chem. 2010, 53, 2409.
[50]
Nishimura, T.; Kitajima, K. J. Org. Chem. 1979, 44, 818.
[51]
Little, T. L.; Webber, S. E. J. Org. Chem. 1994, 59, 7299.
[52]
Molina, P.; Fresneda, P.; Sanz, M. J. Org. Chem. 1999, 64, 2540.
[53]
Liu, S.; Shao, J.; Guo, X.; Luo, J.; Zhao, M.; Zhang, G. L.; Yu, Y. P. Tetrahedron 2014, 70, 1418.
[54]
Guo, X.; Chen, W. T.; Chen, B. H.; Huang, W.; Qi, W. X.; Zhang, G. L.; Yu, Y. P. Org. Lett. 2015, 17, 1157.
[55]
Burnstock, G.; Verkhratsky, A. Acta. Physiol. 2009, 195, 415.
[56]
Murray, J. M.; Bussiere, D. E. Chemogenomics 2009, 575, 47.
[57]
Li, X.; Kang, H.; Liu, X.; Liu, Z.; Shu, K.; Chen, X.; Zhu, S. J. Huazhong Univ. Sci. Technol. Med. Sci. 2012, 32, 257.
[58]
Gillespie, R. J.; Bamford, S. J.; Botting, R. J. Med. Chem. 2009, 52, 33.
[59]
http://clinicaltrials.gov/ct2/show/NCT00442780
[60]
Kalinina, S. A.; Kalinin, D. V.; Dolzhenko, A. V. Tetrahedron Lett. 2013, 54, 5537.
[61]
Lim, F. P. L.; Luna, G; Dolzhenko, A. V. Tetrahedron Lett. 2015, 56, 7016.
[62]
Kalinin, D.; Kalinina, S.; Dolzhenko, A. Heterocycles 2013, 87, 147.
[63]
Lim, F. P. L.; Low, S. T.; Ho, E. L. K.; Halcovitch, N. R.; Tiekinkc, E. R. T.; Dolzhenko, A. V. RSC Adv. 2017, 7, 51062.
[64]
Li, T.; Senesi, A. J.; Lee, B. Chem. Rev. 2016, 116, 80.
[65]
Mahfoudh, M.; Abderrahim, R.; Leclerc, E. Eur. J. Org. Chem. 2017, 2017, 2856.
[66]
Zhang, L.; Fan, J.; Chong, J. H. Bioorg. Med. Chem. Lett. 2011, 21, 5633.
[67]
Lim, S. M.; Xie, T.; Westover, K. D. Bioorg. Med. Chem. Lett. 2015, 25, 3382.
[68]
Venkatesan, G.; Paira, P.; Cheong, S. L. Bioorg. Med. Chem. Lett. 2014, 22, 1751.
[69]
(a) Woller, K. R.; Curtin, M. L.; Frank, K. E.; Josephsohn, N. S.; Li, B. C.; Wishart, N. WO 156698, 2011.
[69]
(b) Wainwright, P.; Maddaford, A.; Simms, M. Synlett 2011, 1900.
[70]
Tsai, S. E.; Yen, W. P.; Tseng, C. C.; Xie, J. J.; Liou, M. Y.; Li, Y. T.; Uramaru, N.; Wong, F. F. Tetrahedron 2018, 74, 2787.
[71]
Tseng, C. C.; Tsai S. E.; Li S. M. Wong, F. F. J. Org. Chem. 2019, 84, 16157.
[72]
Seela, F.; Steker, H. Heterocycles 1985, 23, 2521.
[73]
Su, L.; Sun, K.; Pan, N.; Liu, L.; Sun, M. L.; Dong, J. Y.; Zhou, Y. B. Org. Lett. 2018, 20, 3399.
[74]
(a) Qiao, Q.; Dominique, R.; Goodnow, Jr. R. Tetrahedron Lett. 2008, 49, 3682.
[74]
(b) Desroy, N.; Moreau, F.; Briet, S. Bioorg. Med. Chem. 2009, 17, 1276.
[75]
Bey, E.; Marchais-Oberwinkler, S.; Werth, R. J. Med. Chem. 2008, 51, 6725.
[76]
Chalopin, T.; Dorta, D. A.; Sivignon, A. Org. Biomol Chem. 2016, 14, 3913.
[77]
Ishita, K.; Stefanopoulos, S.; Khalil, A. Bioorg. Med. Chem. 2018, 26, 2251.
[78]
Nettekoven, M.; Guba W.; Neidhart, W. ChemMedChem 2006, 1, 45.
[79]
Fu, R. G.; Wang, Y.; Xia, F. J. Org. Chem. 2019, 84, 12237.
[80]
(a) Luo, L.; Meng, L.; Sun, Q. Tetrahedron Lett. 2014, 55, 259.
[80]
(b) Gruner, M.; Boettcher, G.; Gewald, K. J. Heterocycl. Chem. 2008, 45, 1071.
[81]
(a) Kumar, S. V.; Parameshwarappa, G.; Ila, H. J. Org. Chem. 2013, 78, 7362.
[81]
(b) Hodgetts, K. J.; Kershaw, M. T. Org. Lett. 2003, 5, 2911.
[81]
(c) Hodgetts, K. J.; Kershaw, M. T. Org. Lett. 2002, 4, 1363.
[82]
Guo, S.; Zhao, D.; Zhu, Y. Synth. Commun. 2017, 47, 1758.
[83]
Avadhani, A.; Iniyavan, P.; Kumar, Y.; Ila, H. J. Org. Chem. 2021, 86, 8508.
[84]
(a) Romagnoli, R.; Baraldi, P. G.; Salvador, M. K. J. Med. Chem. 2012, 55, 5433.
[84]
(b) Romagnoli, R.; Baraldi, P. G.; Cara, C. L. Eur. J. Med. Chem. 2011, 46, 6015.
[85]
Kathiravan, M. K.; Salake, A. B.; Chothe, A. S. Bioorg. Med. Chem. 2012, 20, 5678.
[86]
Mahfoudh, M.; Abderrahim, R.; Leclerc, E. Eur. J. Org. Chem. 2017, 2017, 2856.
[87]
Chaurasia, S. R.; Dange, R.; Bhanage, B. M. Catal. Commun. 2020, 137, 105933.
[88]
Wolf, F. J.; Pfister 3rd. K.; Wilson, Jr, R. M.; Robinson, C. A. J. Am. Chem. Soc. 1954, 76, 3551.
[89]
Belsky, A. J.; Li, T. J.; Brill, T. B. J. Supercrit. Fluids 1997, 10, 201.
[90]
Zhao, P.; Zhou, Y.; Yu, X. X. Huang, C.; Wu, Y. D.; Yin, G. D. Org. Lett. 2020, 22, 8528.
[91]
(a) Wu, C. P.; Lusvarghi, S.; Wang, J. C. Mol. Pharmaceutics 2019, 16, 3040.
[91]
(b) Grünewald, S.; Politz, O.; Bender, S. Int. J. Cancer 2019, 145, 1346.
[91]
(c) Rouge, T. L. M.; Galluzzi, L.; Olaussen, K. A. Cancer Res. 2007, 67, 6253.
[92]
(a) Dixon, J. A.; Phillips, B.; Achebe, F.; Kluender, H. C. E.; Newcom, J.; Parcella, K.; Magnuson, S.; Hong, Z.; Zhang, Z.; Liu, Z.; Khire, U.; Wang, L.; Michels, M.; Chandler, B.; ,O’Connor S. US 8143393, 2006.
[92]
(b) O'Connor, S.; Dumas, J.; Lee, W.; Dixon, J.; Cantin, D.; Gunn, D.; Burke, J.; Phillips, B.; Lowe, D.; Shelekhin, T.; Wang, G.; Ma, X.; Ying, S.; McClure, A.; Achebe, F.; Lobell, M.; Ehrgott, F.; Iwuagwu, C.; Parcella, K. US 8431695, 2006.
[92]
(c) Song, Y.; Zhan, P.; Zhang, Q.; Liu, X. Curr. Pharm. Des. 2013, 19, 1528.
[92]
(d) Cascioferro, S.; Parrino, B.; Spano, V.; Carbone, A.; Montalbano, A.; Barraja, P.; Diana, P.; Cirrincione, G. Eur. J. Med. Chem. 2017, 142, 328.
[93]
Paymode, D. J.; Cardoso, F. S. P.; Agrawal, T.; Tomlin, J. W.; Cook, D. W.; Burns, J. M.; Stringham, R. W.; Sieber, J. D.; Snead, D. R. Org. Lett. 2020, 22, 7656.
[94]
Knapp, R. R.; Tona, V.; Okada, T.; Sarpong, R.; Garg, N. K. Org. Lett. 2020, 22, 8430.
[95]
Wei, Z.; Zhang, Q.; Tang, M. Org. Lett. 2021, 23, 4436.
[96]
Liu, X.; Liu, H.; Bian, C.; Hu, Y. L. J. Org. Chem. 2022, 87, 5882.
文章导航

/

〈 〉